INVO Bioscience | 8-K: INVO Reports Record Third Quarter 2023 Financial Results Company Expects to Host Conference Call Shortly After November 20, 2023 Following the Progress of Certain Closing Conditions Pertaining to the Announced Merger Agreement with

SEC · Nov 14, 2023 05:10

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

INVO Bioscience | 8-K: INVO Reports Record Third Quarter 2023 Financial Results Company Expects to Host Conference Call Shortly After November 20, 2023 Following the Progress of Certain Closing Conditions Pertaining to the Announced Merger Agreement with

Risk Disclaimer